Skip to main content
logo
CG Oncology, Inc. (CGON)
NASDAQ: CGON · Real-Time Price · USD
61.96
-2.72 (-4.21%)
Nov 2, 2026, 4:00 PM EST - Market closed

CG Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5,4923,3492,183---
Market Cap Growth
66.47%53.40%----
Enterprise Value
4,4732,6761,643---
Last Close Price
61.9641.5228.68---

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
881.85829.031916.94---
PB Ratio
5.324.452.98---
P/TBV Ratio
5.394.512.98---

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
718.16662.441442.48---

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.0100.000.130.38
Net Debt / Equity Ratio
-0.99-0.98-1.01-1.01-1.02-0.96
Net Debt / EBITDA Ratio
4.083.886.473.383.623.06
Net Debt / FCF Ratio
5.685.559.404.104.282.80
Asset Turnover
0.010.010.000.000.00-
Quick Ratio
21.7824.0934.7313.179.328.97
Current Ratio
22.2224.6335.3013.629.549.78
Return on Equity (ROE)
-26.41%-21.67%-19.18%-31.36%-42.85%-
Return on Assets (ROA)
-17.67%-15.42%-15.02%-19.97%-21.34%-
Return on Capital Employed (ROCE)
-24.30%-25.10%-15.60%-30.00%-26.60%-23.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-4.40%-4.81%-4.03%---
FCF Yield
-3.27%-3.96%-3.62%---
Buyback Yield / Dilution
-14.15%-23.69%-1343.03%-15.77%-2.48%-
SEC Filings: 10-K · 10-Q